PRMT5 and hepatocellular carcinoma: Moreover, we divided the 75 HCC samples into four groups: high CDK4 and high PRMT5 expression, low CDK4 and low PRMT5 expression, high CDK4 and low PRMT5 expression, low CDK4 and high PRMT5 expression (the representative samples were shown in Supplementary Figure S1).